Biogen and Japanese drugmaker Eisai created a surge in hope for an experimental Alzheimer’s drug called BAN2401, after the companies announced positive results in a late-stage trial. That hope ...
WASHINGTON (MarketWatch) -- The Federal Reserve can't afford to overreact to just one number, no matter how dramatic it may be, said Fed Gov. Randall Kroszner. In remarks to reporters at a seminar on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback